#patent-disputes tag

BioNTech to Buy CureVac in $1.25B Stock Deal That Would Also End mRNA Patent Dispute - MedCity News

BioNTech acquires CureVac to strengthen mRNA capabilities and mitigate legal risks amidst ongoing patent disputes.

Temporary restraining order against Shira Perlmutter's firing denied, but legal avenues may persist.

Eighth Circuit avoids key copyright ruling, leaving important questions unresolved.

General Motors invests $888 million in next-gen V-8 engine plant.

Intel has another shot at reversing $3 billion in damages over patent disputes.

The Unified Patent Court (UPC) is now central to pharmaceutical patent disputes in Europe, affecting strategies for innovators and generics.

EPO oppositions significantly impact UPC proceedings, influencing both patent validity and injunctive relief.